Commentary: The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity

Commentary: The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity

Bibliographic Details
Main Authors:	Barbara Barbaro, Ilaria Romito, Anna Alisi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-10-01
Series:	Frontiers in Genetics
Subjects:	NAFLD (non-alcoholic fatty liver disease) NASH (non-alcoholic steatohepatitis) Phf2 histone modification epigenetics (MeSH)
Online Access:	https://www.frontiersin.org/article/10.3389/fgene.2018.00443/full

Similar Items

Preventative and Therapeutic Effects of Astaxanthin on NAFLD
by: Nor Hafiza Sayuti, et al.
Published: (2023-08-01)

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
by: Christina-Maria Flessa, et al.
Published: (2022-12-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis
by: Stamatina Vogli, et al.
Published: (2023-08-01)

Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
by: Clémence Rives, et al.
Published: (2020-12-01)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Nelson Kei, et al.
Published: (2023-09-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
by: Christoph Roderburg, et al.
Published: (2023-04-01)

Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages
by: Charles Drummer, et al.
Published: (2023-01-01)

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
by: Rodrigo Zamignan Carpi, et al.
Published: (2022-08-01)

A case of metabolic syndrome, positive antinuclear antibodies and cirrhosis.
by: Alessandro Grasso
Published: (2007-09-01)

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
by: Martina Colognesi, et al.
Published: (2020-07-01)

Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile
by: Helma P. Cotrim, et al.
Published: (2011-01-01)

Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice
by: Daniel Cabrera, et al.
Published: (2021-09-01)

NAFLD: Mechanisms, Treatments, and Biomarkers
by: Fatiha Nassir
Published: (2022-06-01)

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
by: Deniz Tümen, et al.
Published: (2022-12-01)

Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease
by: HAO Dandan, ZHANG Lei, BAI Chunying
Published: (2023-08-01)

Loss of hepatic VMP1 trapped VLDL in the bilayer of endoplasmic reticulum membrane
by: Hong-Min Ni, et al.
Published: (2023-06-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update
by: Chu-Jun Deng, et al.
Published: (2022-10-01)

ULTRASOUND GUIDED HYDROSTATIC REDUCTION OF INTUSSUSCEPTIONS IN CHILDREN WITH LATE PRESENTATION
by: Nadeem Ullah, et al.
Published: (2019-03-01)

POSITIVE ATTITUDE AND STRESS AMONG ADULTS WITH CORONARY HEART DISEASES IN FAISALABAD
by: Syed Muhammad Imran Haider Zaidi, et al.
Published: (2018-09-01)

CAUSES OF LOWER LIMB AMPUTATION IN PATIENTS REGISTERED AT PAKISTAN INSTITUTE OF PROSTHETIC AND ORTHOTIC SCIENCES PESHAWAR-PAKISTAN
by: Aziz Ahmad, et al.
Published: (2019-03-01)

S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma
by: Etienne Delangre, et al.
Published: (2022-09-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
by: Nicha Wongjarupong, et al.
Published: (2017-12-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

COVID-19 and MAFLD/NAFLD: An updated review
by: Ali Nowroozi, et al.
Published: (2023-03-01)

FUNCTIONAL RECOVERY IN PATIENTS WITH POST-TRAUMATIC SPINAL CORD INJURIES: AN OUTCOME OF GROSS MOBILITY AT PARAPLEGIC CENTER PESHAWAR, PAKISTAN
by: Amir Zeb, et al.
Published: (2019-03-01)

Treatments for NAFLD: State of Art
by: Alessandro Mantovani, et al.
Published: (2021-02-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites
by: Xingyu Li, et al.
Published: (2023-05-01)

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
by: Alessandro Mantovani, et al.
Published: (2022-02-01)

Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
by: Sukrit Kanchanasurakit, et al.
Published: (2022-05-01)

Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
by: Yang Xiao, et al.
Published: (2021-08-01)

NASH and cryptogenic cirrhosis: A histological analysis†† Financial Support/Grants: This research supported in part by the Intramural Research Program of the NIH, National Cancer Institute.
by: Stephen H. Caldwell, et al.
Published: (2009-10-01)

Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19
by: Cheng Dong, et al.
Published: (2020-09-01)

PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL
by: Hagen Roland Witzel, et al.
Published: (2022-12-01)